antibody

Tocilizumab (Anti-Human IL6R) is a neutralizing antibody against human interleukin-6 receptor (IL-6R) that blocks the binding of IL-6 to IL-6R, thereby inhibiting both classical and trans signaling. It can be used to study rheumatoid arthritis and has been suggested as a possible drug for the treatment of severe COVID-19.

Daratumumab is a human monoclonal antibody that targets CD38 a cell surface protein that is overexpressed on multiple myeloma MM) cells.

Ranibizumab is a humanized monoclonal antibody fragment designed to target and inhibit vascular endothelial growth factor (VEGF), including VEGF110, VEGF121, and VEGF165. Ranibizumab's ability to selectively target and neutralize VEGF-A isoforms has made it a crucial component of research and treatment strategies for wet wet age-related macular degeneration (AMD).

Anti-Mouse PD-1 Antibody (RMP1-14) is an IgG2a antibody inhibitor against mouse PD-1 and can block PD-1/PD-L1 signaling.

Anti-Mouse PD-L1 Antibody (10F.9G2) is an IgG-class antibody against mouse PD-L1.

Anti-ETBR Antibody (DEDN6526A Naked Antibody) is a highly specific monoclonal antibody targeting the endothelin B receptor (ETBR) and serves as the antibody for the ADC molecule DEDN6526A. DEDN6526A (RG-7636) is a humanized ETBR-targeting antibody-drug conjugate developed for melanoma research.

Anti-EFNA4 Antibody (PF-06647263 Naked Antibody) is a monoclonal antibody targeting EFNA4 and can be used for the synthesis of the ADC PF-06647263.

Anti-SEZ6 Antibody (SC17) is an IgG1 monoclonal antibody targeting SEZ6, which can be used for the synthesis of antibody-drug conjugates (ADCs), such as ABBV-011.

Anti-STEAP2 Antibody (AZD0516 antibody) is a selective inhibitor of the prostate-specific six transmembrane epithelial antigen 2 (STEAP2). It inhibits the proliferation, migration, and invasion of prostate cancer cells by blocking the STEAP2-mediated ERK/MAPK signaling pathway. Anti-STEAP2 Antibody shows potential for prostate cancer research.

IgG has four forms, provides the majority of antibody-based immunity against invading pathogens. The only antibody capable of crossing the placenta to give passive immunity to the fetus. Eliminates pathogens in the early stages of B cell-mediated (humoral

Anti-Mouse CD4 Antibody (2G5.D) is an anti-mouse CD4 antibody widely used in research and experiments in the field of life sciences.

Anti-IL-6R Reference Antibody (Vobarilizumab-Fc) is a humanized monoclonal antibody targeting IL-6Ra/CD126, which can be used in research related to immune system diseases.

RG7841 is a humanized antibody targeting Ly6E, which can be used to study lung cancer.

Anti-Beta Klotho Antibody (Fazpilodemab) is a monoclonal antibody that targets Beta Klotho. The sequence is referenced from Fazpilodemab.

Anti-CD46 Antibody (FOR46 Naked Antibody) is a humanized antibody targeting CD46, used in prostate disease and myeloma research.

Anti-Mouse CD209b Antibody is an IgG1 inhibitor targeting mouse CD209b, sourced from the Armenian hamster.

Anti-Mouse CD28 Antibody (37.51) is a murine IgG-like antibody targeting CD28.

Anti-Mouse CD3 Antibody (17A2) is a murine IgG2b class antibody targeting CD3, which can be used to study TCR signaling, T cell activation and antigen recognition.

Anti-Mouse CD32/CD16 Antibody is a rat-derived IgG2b inhibitor targeting the mouse CD32/CD16 antigens.

Anti-Mouse CD44 Antibody (IM7) is a monoclonal antibody targeting CD44 in mice.

Anti-Mouse CD8 beta Antibody is a rat-derived IgG1 inhibitor that targets the mouse CD8 beta protein.

Anti-Mouse CD8a Antibody, a rat-derived IgG2a isotype inhibitor, is specific for mouse CD8a.

Anti-Mouse CTLA-4 Antibody (9D9) is an IgG2b monoclonal antibody that binds CTLA-4, blocking B7 interaction. It enhances T cell function by modulating CD8+/Treg ratios and is used in colon cancer and melanoma research.

Anti-Mouse IFN Gamma Antibody is a host Armenian Hamster-derived anti-mouse IFN gamma immunoglobulin G (IgG) inhibitor.